Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
BIOCRYST PHARMACEUTICALS INC
Ticker: BCRX
CUSIP: 09058V103
Class: Common Stock
Catalyst Funds Management Pty Ltd's Holding History (CIK: 0001896150)
Note: Option positions (PUT/CALL) are excluded.
Q3 2024
Shares
24,900
Value ($000)
$189
Avg Close
$7.60
Range
$6.17 - $8.88
Q2 2024
Shares
28,500
Value ($000)
$176
Avg Close
$5.52
Range
$4.03 - $6.99
Period
Shares
Value ($000)
Average Close
Price Range
Q3 2024
24,900
$189
$7.60
$6.17 - $8.88
Q2 2024
28,500
$176
$5.52
$4.03 - $6.99